1Hilleman MR.Overview of the pathogenesis,prophylaxis and therapeusis of viral hepatitis B,with focus on reduction to practical applications[J].Vaccine,2001,19(15-16):1837-1848.
3Pol S,Michel ML,Brechot C.Immune therapy of hepatitis B virus chronic infection[J].Hepatology,2000,31(2):548-549.
4Couillin I,Pol S,Mancini M,et al.Specific vaccine therapy in chronic hepatitis B:induction of T cell proliferative responses specific for envelope antigens[J].J Infect Dis,1999,180(1):15-26.
5Ren F,Hino K,Yamaguchi Y,et al.Cytokine-dependent antiviral role of CD4-positive T cells in therapeuticvaccination against chronic hepatitis B virus infection[J].J Med Virol,2003,71(3):376-384.
6Helvaci M,Kizilgunesler A,Kasirga E,et al.Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B[J].J Gastroenterol Hepatol,2004,19(7):785-791.
7Heintges T,Petry W,Kaldewey M,et al.Combination therapy of active HbsAg vaccination and interferon-alpha in interferonalpha nonresponders with chronic hepatitis B[J].Dig Dis Sci,2001,46(4):901-906.